Silver Oak Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $170K | Buy |
+381
| New | +$170K | 0.01% | 654 |
|
|
2024
Q4 | – | Sell |
-1,219
| Closed | -$553K | – | 661 |
|
|
2024
Q3 | $553K | Buy |
1,219
+20
| +2% | +$9.07K | 0.06% | 318 |
|
|
2024
Q2 | $562K | Buy |
1,199
+283
| +31% | +$133K | 0.08% | 203 |
|
|
2024
Q1 | $383K | Sell |
916
-1,433
| -61% | -$599K | 0.06% | 260 |
|
|
2023
Q4 | $956K | Buy |
2,349
+1,355
| +136% | +$551K | 0.13% | 170 |
|
|
2023
Q3 | $346K | Sell |
994
-950
| -49% | -$330K | 0.08% | 206 |
|
|
2023
Q2 | $684K | Buy |
+1,944
| New | +$684K | 0.11% | 191 |
|
|
2022
Q4 | – | Sell |
-994
| Closed | -$346K | – | 492 |
|
|
2022
Q3 | $346K | Buy |
+994
| New | +$346K | 0.08% | 206 |
|